Indonesia stands at the forefront of the global smoking epidemic, with 64.7% of its male population actively smoking, the highest rate worldwide.

Smoking-related diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and heart disease claim 300,000 lives annually, marking a severe public health crisis. This report explores how a strategic approach integrating Tobacco Harm Reduction (THR), cessation programs, and enhanced lung cancer treatment could save 4.6 million lives by 2060. It emphasizes the urgent need to adopt smoke-free nicotine alternatives to mitigate the devastating health consequences of tobacco use.
The economic burden of smoking in Indonesia is equally alarming. With smoking-related healthcare costs and productivity losses far exceeding cigarette tax revenues, the strain on the national economy is immense. This report presents a roadmap for addressing these challenges, advocating for policies that make harm-reduction products more accessible and affordable. By adopting these measures, Indonesia has the opportunity to not only reduce the human toll of smoking but also to alleviate the financial pressures on its healthcare system, creating a healthier and more sustainable future.Watch the official report launch:[divider line_type=”No Line” custom_height=”10px”]